siRNA therapy lowers triglycerides in patients with uncommon health condition

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and reduced the threat of pancreatitis in clients along with constant chylomicronemia, with or even without a genetic diagnosis.